Cannabis Bioscience International Holdings, Inc. (CBIH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue Quarterly

0 9M 18M 27M Q1 '11: 21.2M Q2 '11: 25.9M Q3 '11: 20.8M Q1 '12: 17.3M Q2 '12: 15.5M Q3 '12: 8.6M Q1 '23: 136.6K Q2 '23: 82.6K Q3 '23: 51.3K Q4 '23: 46.4K Q1 '24: 72.8K Q2 '24: 63.7K Q3 '24: 36.4K Q4 '24: 75.9K Q1 '25: 178.9K Q2 '25: 74.2K Q3 '25: 14.9K Q4 '25: 35K Q1 '26: 24.2K Q2 '26: 53.3K Q3 '26: 11.2K Q3 '11 Q3 '12 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

-3M 0 3M 6M 9M Q1 '11: 6.1M Q2 '11: 7.2M Q3 '11: 8.5M Q1 '12: 6.2M Q2 '12: 5M Q3 '12: 1.8M Q1 '23: 90.3K Q2 '23: 75.5K Q3 '23: 27.1K Q4 '23: 30.4K Q1 '24: 64K Q2 '24: 48.7K Q3 '24: 24.6K Q4 '24: 66K Q1 '25: 170.5K Q2 '25: 66.4K Q3 '25: -4.5K Q4 '25: 30.4K Q1 '26: 16.1K Q2 '26: 42.8K Q3 '26: 8.2K Q3 '11 Q3 '12 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income Quarterly

-2M 0 2M 4M 6M Q1 '11: 4.7M Q2 '11: 5.4M Q3 '11: -1.6M Q1 '12: 4.7M Q2 '12: 2.8M Q3 '12: -1M Q1 '23: -240K Q2 '23: -183.6K Q3 '23: -284.9K Q4 '23: -274.9K Q1 '24: -176.8K Q2 '24: -94.5K Q3 '24: -160K Q4 '24: -29.6K Q1 '25: -97.6K Q2 '25: -59.6K Q3 '25: -129.2K Q4 '25: -134.9K Q1 '26: -74.8K Q2 '26: -95.9K Q3 '26: -93.3K Q3 '11 Q3 '12 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-2M 0 2M 4M 6M Q1 '11: 4M Q2 '11: 4.9M Q3 '11: -1.7M Q1 '12: 3.1M Q2 '12: 1.8M Q3 '12: -1.2M Q1 '23: -212K Q2 '23: -219.9K Q3 '23: -324.7K Q4 '23: -276K Q1 '24: -181.8K Q2 '24: -124.4K Q3 '24: -209.2K Q4 '24: -135.9K Q1 '25: -76.3K Q2 '25: -79.5K Q3 '25: -181.2K Q4 '25: -211.7K Q1 '26: -82.6K Q2 '26: -117K Q3 '26: -103.9K Q3 '11 Q3 '12 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue Quarterly

0 7M 14M 21M Q1 '11: 15.1M Q2 '11: 18.7M Q3 '11: 12.3M Q1 '12: 11.1M Q2 '12: 10.5M Q3 '12: 6.8M Q1 '23: 46.2K Q2 '23: 7.1K Q3 '23: 24.1K Q4 '23: 16K Q1 '24: 8.8K Q2 '24: 15.1K Q3 '24: 11.8K Q4 '24: 9.9K Q1 '25: 8.4K Q2 '25: 7.8K Q3 '25: 19.4K Q4 '25: 4.5K Q1 '26: 8.1K Q2 '26: 10.5K Q3 '26: 3K Q3 '11 Q3 '12 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow Quarterly

-2M -1M 0 1M 2M 3M Q1 '11: 333.7K Q2 '11: 960.2K Q3 '11: -703.2K Q1 '12: 693.1K Q2 '12: 2.9M Q3 '12: -1.3M Q3 '23: -201.2K Q4 '23: -187.9K Q1 '24: -74.6K Q2 '24: -221.2K Q3 '24: -9.1K Q4 '24: -174.4K Q1 '25: -30.4K Q2 '25: -72.1K Q3 '25: -82.8K Q4 '25: -144.3K Q1 '26: -103.7K Q2 '26: -5.5K Q3 '26: -14.6K Q1 '11 Q1 '12 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q1 '11: 228.5K Q2 '11: 729K Q3 '11: -873.6K Q1 '12: 485.8K Q2 '12: -1.2M Q3 '12: -1.6M Q1 '11 Q2 '11 Q3 '11 Q1 '12 Q2 '12 Q3 '12

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 4B 8B 12B Q2 '23: 8.1B Q3 '23: 7.9B Q1 '24: 10.3B Q2 '24: 10.3B Q3 '24: 10.4B Q1 '25: 10.5B Q2 '25: 10.5B Q3 '25: 10.7B Q1 '26: 11.6B Q2 '26: 11.6B Q3 '26: 11.6B Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 Q4 '23: -0.00 Q1 '24: -0.00 Q2 '24: -0.00 Q3 '24: -0.00 Q4 '24: -0.00 Q1 '25: -0.00 Q2 '25: -0.00 Q3 '25: -0.00 Q4 '25: -0.00 Q1 '26: -0.00 Q2 '26: -0.00 Q3 '26: -0.00 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.